A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) — Stella

Recruiting

Back to Genital Psoriasis trials

Trial locations(1 site)

Austria

Medizinische Universität Graz, Graz, Styria

Key details

Sponsor

Almirall, S.A.

Enrollment target

~110 participants

Started

November 2023

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 99 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov